Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Workday, Inc.WDAY · Entity 1785 | Chief Products Officer | December 16, 2019 | December 18, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Workday, Inc.
Report date December 16, 2019 · Filed December 18, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 149,075 |
Last balance in matching sequence
After 2019-12-16 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2019-12-16 · Sale · Disposed 1,433 · Balance 152,932 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $160.2700 to $161.2699, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3: Includes 109,494 restricted stock units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Row 2 · 2019-12-16 · Sale · Disposed 3,857 · Balance 149,075 F4: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $160.0000 to $160.9999, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3: Includes 109,494 restricted stock units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. |
| Class A Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 43,896 |
Reported balance
Holding disclosure · report date 2019-12-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 43,896 F6: The shares are held in a joint revocable trust dated October 15, 1999. The trust is in the name of the Reporting Person and his spouse, who are both sole trustees and beneficiaries of the trust. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.05 · Expires 2022-05-04 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2019-12-16 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 40,000 F7: This stock option grant became fully vested on March 3, 2018. F8: All shares of Class A and Class B Common Stock will convert automatically into shares of a single class of Common Stock upon the earliest to occur of the following: (a) upon the election by the holders of a majority of the then outstanding shares of Class B Common Stock, (b) the date when the number of outstanding shares of Class B Common Stock represents less than 9% of all outstanding shares of Class A and Class B Common Stock, (c) October 11, 2032 or (d) nine (9) months after the death of the later to die of David A. Duffield and Aneel Bhusri. The shares of Class A and Class B Common Stock have no expiration date. F9: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon any transfer, whether or not for value, except for certain permitted transfers described in, and transfers to any "permitted transferee" as defined in, the Issuer's restated certificate of incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.30 · Expires 2021-02-18 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2019-12-16 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 25,000 F10: This stock option grant became fully vested on July 1, 2016. F8: All shares of Class A and Class B Common Stock will convert automatically into shares of a single class of Common Stock upon the earliest to occur of the following: (a) upon the election by the holders of a majority of the then outstanding shares of Class B Common Stock, (b) the date when the number of outstanding shares of Class B Common Stock represents less than 9% of all outstanding shares of Class A and Class B Common Stock, (c) October 11, 2032 or (d) nine (9) months after the death of the later to die of David A. Duffield and Aneel Bhusri. The shares of Class A and Class B Common Stock have no expiration date. F9: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon any transfer, whether or not for value, except for certain permitted transfers described in, and transfers to any "permitted transferee" as defined in, the Issuer's restated certificate of incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $160.2700 to $161.2699, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
F3: Includes 109,494 restricted stock units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates.
F4: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $160.0000 to $160.9999, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
F6: The shares are held in a joint revocable trust dated October 15, 1999. The trust is in the name of the Reporting Person and his spouse, who are both sole trustees and beneficiaries of the trust.
F7: This stock option grant became fully vested on March 3, 2018.
F8: All shares of Class A and Class B Common Stock will convert automatically into shares of a single class of Common Stock upon the earliest to occur of the following: (a) upon the election by the holders of a majority of the then outstanding shares of Class B Common Stock, (b) the date when the number of outstanding shares of Class B Common Stock represents less than 9% of all outstanding shares of Class A and Class B Common Stock, (c) October 11, 2032 or (d) nine (9) months after the death of the later to die of David A. Duffield and Aneel Bhusri. The shares of Class A and Class B Common Stock have no expiration date.
F9: Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon any transfer, whether or not for value, except for certain permitted transfers described in, and transfers to any "permitted transferee" as defined in, the Issuer's restated certificate of incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date.
F10: This stock option grant became fully vested on July 1, 2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2019 Filed Dec 18, 2019 16:34 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 3,857 | $160.30 | $618,274.79 |
DisclosureSEC source: 0001327811-19-000215 · wf-form4_157670482470173.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,075 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $160.0000 to $160.9999, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 109,494 restricted stock units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 16:34 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,433 | $160.42 | $229,886.16 |
DisclosureSEC source: 0001327811-19-000215 · wf-form4_157670482470173.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,932 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $160.2700 to $161.2699, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 109,494 restricted stock units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 20:33 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 200 | $164.64 | $32,928.00 |
DisclosureSEC source: 0001327811-19-000204 · wf-form4_157594156889992.xml · nonDerivative · entry 4 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,365 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $164.2200 to $165.2199, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 20:33 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 500 | $162.24 | $81,122.00 |
DisclosureSEC source: 0001327811-19-000204 · wf-form4_157594156889992.xml · nonDerivative · entry 3 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,565 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $162.0600 to $163.0599, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 20:33 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,264 | $161.48 | $204,104.53 |
DisclosureSEC source: 0001327811-19-000204 · wf-form4_157594156889992.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,065 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $161.0200 to $162.0199, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 20:33 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,500 | $160.43 | $240,649.95 |
DisclosureSEC source: 0001327811-19-000204 · wf-form4_157594156889992.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,329 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $159.8900 to $160.8899, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. F4 · balance_after: Includes 63 shares of Class A Common Stock that were purchased through the Issuer's Employee Stock Purchase Program. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 18:56 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 700 | $184.41 | $129,087.00 |
DisclosureSEC source: 0001327811-19-000189 · wf-form4_157135297608349.xml · nonDerivative · entry 7 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,766 F6 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $183.9200 to $184.9199, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 18:56 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,700 | $183.03 | $311,155.93 |
DisclosureSEC source: 0001327811-19-000189 · wf-form4_157135297608349.xml · nonDerivative · entry 6 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,466 F6 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $182.5800 to $183.5799, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 18:56 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 100 | $181.55 | $18,155.00 |
DisclosureSEC source: 0001327811-19-000189 · wf-form4_157135297608349.xml · nonDerivative · entry 5 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,166 F6 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 18:56 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,000 | $181.05 | $181,054.00 |
DisclosureSEC source: 0001327811-19-000189 · wf-form4_157135297608349.xml · nonDerivative · entry 4 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,266 F6 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $180.4900 to $181.4899, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 18:56 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,280 | $184.84 | $236,601.09 |
DisclosureSEC source: 0001327811-19-000189 · wf-form4_157135297608349.xml · nonDerivative · entry 3 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,266 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $184.5400 to $185.5399, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 18:56 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,000 | $183.96 | $183,957.00 |
DisclosureSEC source: 0001327811-19-000189 · wf-form4_157135297608349.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,546 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $183.5400 to $184.5399, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 18:56 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,391 | $182.79 | $254,265.76 |
DisclosureSEC source: 0001327811-19-000189 · wf-form4_157135297608349.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,546 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $182.4100 to $183.4099, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 112,400 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 18:15 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 513 | $173.73 | $89,125.49 |
DisclosureSEC source: 0001327811-19-000171 · wf-form4_156884492628067.xml · nonDerivative · entry 6 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,937 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $173.1900 to $174.1899, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 164,937 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 18:15 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 2,587 | $172.92 | $447,338.87 |
DisclosureSEC source: 0001327811-19-000171 · wf-form4_156884492628067.xml · nonDerivative · entry 5 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,450 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $172.1400 to $173.1399, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 164,937 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 18:15 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 200 | $171.48 | $34,296.00 |
DisclosureSEC source: 0001327811-19-000171 · wf-form4_156884492628067.xml · nonDerivative · entry 4 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,037 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $171.0700 to $172.0699, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 164,937 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 18:15 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 100 | $168.68 | $16,868.00 |
DisclosureSEC source: 0001327811-19-000171 · wf-form4_156884492628067.xml · nonDerivative · entry 3 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,237 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · balance_after: Includes 164,937 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 18:15 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 100 | $166.11 | $16,611.00 |
DisclosureSEC source: 0001327811-19-000171 · wf-form4_156884492628067.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,337 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · balance_after: Includes 164,937 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 18:15 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,391 | $173.66 | $241,567.04 |
DisclosureSEC source: 0001327811-19-000171 · wf-form4_156884492628067.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,437 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $173.3600 to $174.3599, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 164,937 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 19:32 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 200 | $177.58 | $35,516.00 |
DisclosureSEC source: 0001327811-19-000158 · wf-form4_156772635729123.xml · nonDerivative · entry 4 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,828 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $177.4800 to $178.4799, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 122,854 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 19:32 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 500 | $176.42 | $88,209.00 |
DisclosureSEC source: 0001327811-19-000158 · wf-form4_156772635729123.xml · nonDerivative · entry 3 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,028 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $176.1200 to $177.1199, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 122,854 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 19:32 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,256 | $175.14 | $219,974.46 |
DisclosureSEC source: 0001327811-19-000158 · wf-form4_156772635729123.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,528 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $174.8200 to $175.8199, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 122,854 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 19:32 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,600 | $174.33 | $278,923.04 |
DisclosureSEC source: 0001327811-19-000158 · wf-form4_156772635729123.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,784 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $173.7900 to $174.7899, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 122,854 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 18:20 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,600 | $219.90 | $351,847.04 |
DisclosureSEC source: 0001327811-19-000146 · wf-form4_156340204462289.xml · nonDerivative · entry 5 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,384 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $219.5400 to $220.5399, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 122,854 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 18:20 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 400 | $218.69 | $87,477.00 |
DisclosureSEC source: 0001327811-19-000146 · wf-form4_156340204462289.xml · nonDerivative · entry 4 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,984 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $218.3900 to $219.3899, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 122,854 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 18:20 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,444 | $218.03 | $314,833.15 |
DisclosureSEC source: 0001327811-19-000146 · wf-form4_156340204462289.xml · nonDerivative · entry 3 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,384 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $217.3600 to $218.3599, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 122,854 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 18:20 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,801 | $219.81 | $395,875.11 |
DisclosureSEC source: 0001327811-19-000146 · wf-form4_156340204462289.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,828 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $219.4100 to $220.4099, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 122,854 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 18:20 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,995 | $218.43 | $435,776.03 |
DisclosureSEC source: 0001327811-19-000146 · wf-form4_156340204462289.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,629 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $217.9318 to $218.9317, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 122,854 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 19:11 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 866 | $209.68 | $181,587.04 |
DisclosureSEC source: 0001327811-19-000110 · wf-form4_156089948176896.xml · nonDerivative · entry 6 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,624 F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $209.6838 to $210.6837, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F8 · balance_after: Includes 130,401 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 19:11 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 2,000 | $209.13 | $418,261.40 |
DisclosureSEC source: 0001327811-19-000110 · wf-form4_156089948176896.xml · nonDerivative · entry 5 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,490 F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $208.6000 to $209.5999, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F8 · balance_after: Includes 130,401 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 19:11 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 100 | $209.06 | $20,906.00 |
DisclosureSEC source: 0001327811-19-000110 · wf-form4_156089948176896.xml · nonDerivative · entry 4 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,490 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · balance_after: Includes 136,213 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with agrant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 RSUs with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary ofgrant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 19:11 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,038 | $208.19 | $216,100.70 |
DisclosureSEC source: 0001327811-19-000110 · wf-form4_156089948176896.xml · nonDerivative · entry 3 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,590 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $208.0400 to $209.0399, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 136,213 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with agrant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 RSUs with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary ofgrant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 19:11 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,812 | $207.53 | $376,049.98 |
DisclosureSEC source: 0001327811-19-000110 · wf-form4_156089948176896.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,628 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $207.0400 to $208.0399, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 136,213 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with agrant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 RSUs with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary ofgrant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 19:11 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 606 | $206.49 | $125,131.55 |
DisclosureSEC source: 0001327811-19-000110 · wf-form4_156089948176896.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,440 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $205.8700 to $206.8699, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 136,213 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with agrant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 RSUs with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary ofgrant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:46 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 182 | $208.10 | $37,875.07 |
DisclosureSEC source: 0001327811-19-000094 · wf-form4_155961276508438.xml · nonDerivative · entry 5 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,046 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $207.9800 to $208.9799, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 136,213 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 RSUs with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:46 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 125 | $206.81 | $25,851.75 |
DisclosureSEC source: 0001327811-19-000094 · wf-form4_155961276508438.xml · nonDerivative · entry 4 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,228 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $206.7300 to $207.7299, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 136,213 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 RSUs with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:46 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,191 | $205.91 | $245,235.00 |
DisclosureSEC source: 0001327811-19-000094 · wf-form4_155961276508438.xml · nonDerivative · entry 3 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,353 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $205.5200 to $206.5199, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 136,213 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 RSUs with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:46 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,602 | $204.84 | $328,155.92 |
DisclosureSEC source: 0001327811-19-000094 · wf-form4_155961276508438.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,544 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $204.4500 to $205.4499, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 136,213 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 RSUs with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:46 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 400 | $203.80 | $81,518.00 |
DisclosureSEC source: 0001327811-19-000094 · wf-form4_155961276508438.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,146 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $203.2800 to $204.2799, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 136,213 Restricted Stock Units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 RSUs with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. F4 · balance_after: Includes 109 shares of Class A Common Stock that were purchased through the Issuer's Employee Stock Purchase Program. Read SEC document |
| April 22, 2019 Filed Apr 24, 2019 18:04 UTC | Workday, Inc. WDAY · Entity 1785 | GrantClass A Common Stock | 41,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001327811-19-000079 · wf-form4_155614344970951.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,437 F1 · balance_after: Includes 136,213 restricted stock units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 41,763 RSUs with a grant date of 4/22/2019, which will vest as to 25% of the underlying shares on 4/15/2020 and then quarterly thereafter; and ii) 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant and then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 18:29 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 300 | $194.51 | $58,353.99 |
DisclosureSEC source: 0001327811-19-000057 · wf-form4_155554016645962.xml · nonDerivative · entry 7 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,674 F7 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $194.2300 to $195.2299, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 94,450 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2016; ii) 54,247 with a grant date of 4/15/2017, and iii) 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 18:29 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,458 | $193.05 | $281,466.90 |
DisclosureSEC source: 0001327811-19-000057 · wf-form4_155554016645962.xml · nonDerivative · entry 6 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,974 F7 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $192.6800 to $193.6799, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 94,450 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2016; ii) 54,247 with a grant date of 4/15/2017, and iii) 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 18:29 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 500 | $192.01 | $96,007.00 |
DisclosureSEC source: 0001327811-19-000057 · wf-form4_155554016645962.xml · nonDerivative · entry 5 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,432 F7 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $191.5300 to $192.5299, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 94,450 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2016; ii) 54,247 with a grant date of 4/15/2017, and iii) 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 18:29 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 400 | $194.74 | $77,897.00 |
DisclosureSEC source: 0001327811-19-000057 · wf-form4_155554016645962.xml · nonDerivative · entry 4 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,932 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $194.6400 to $195.6399, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 94,450 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2016; ii) 54,247 with a grant date of 4/15/2017, and iii) 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 18:29 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 2,400 | $193.95 | $465,491.52 |
DisclosureSEC source: 0001327811-19-000057 · wf-form4_155554016645962.xml · nonDerivative · entry 3 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,332 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $193.5200 to $194.5199, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 94,450 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2016; ii) 54,247 with a grant date of 4/15/2017, and iii) 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 18:29 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 7,763 | $192.80 | $1,496,699.41 |
DisclosureSEC source: 0001327811-19-000057 · wf-form4_155554016645962.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,732 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $192.4400 to $193.4399, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 94,450 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2016; ii) 54,247 with a grant date of 4/15/2017, and iii) 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 18:29 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 2,089 | $191.98 | $401,044.76 |
DisclosureSEC source: 0001327811-19-000057 · wf-form4_155554016645962.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,495 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $191.4400 to $192.4399, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F3 · balance_after: Includes 94,450 RSUs that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2016; ii) 54,247 with a grant date of 4/15/2017, and iii) 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 18:38 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 774 | $186.86 | $144,630.34 |
DisclosureSEC source: 0001327811-19-000040 · wf-form4_155303509702683.xml · nonDerivative · entry 3 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,584 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $186.6700 to $187.6699, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F2 · balance_after: Includes 120,282 restricted stock units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2014 with remaining vesting dates of 4/15/2018 and 6/15/2018; ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 18:38 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 1,383 | $186.20 | $257,516.40 |
DisclosureSEC source: 0001327811-19-000040 · wf-form4_155303509702683.xml · nonDerivative · entry 2 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,358 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $185.6600 to $186.6599, inclusive. The Reporting Person undertakes to provide to Workday, Inc., any security holder of Workday, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. F2 · balance_after: Includes 120,282 restricted stock units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2014 with remaining vesting dates of 4/15/2018 and 6/15/2018; ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 18:38 UTC | Workday, Inc. WDAY · Entity 1785 | SaleClass A Common Stock | 100 | $184.59 | $18,459.00 |
DisclosureSEC source: 0001327811-19-000040 · wf-form4_155303509702683.xml · nonDerivative · entry 1 Dermetzis Petros · CIK 0001731581 · Chief Products Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,741 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · balance_after: Includes 120,282 restricted stock units (RSUs) that entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, from original grants consisting of i) 46,492 RSUs with a grant date of 4/15/2014 with remaining vesting dates of 4/15/2018 and 6/15/2018; ii) 46,492 RSUs with a grant date of 4/15/2015, 46,492 RSUs with a grant date of 4/15/2016, 54,247 with a grant date of 4/15/2017, and 66,521 RSUs with a grant date of 4/15/2018, each of which vested or will vest as to 25% of the underlying shares on the one-year anniversary of grant then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.